Skip to main content
. 2019 Aug 31;18:165. doi: 10.1186/s12944-019-1108-2

Table 9.

Clinical Characteristics of TRIB1 rs17321515 A allele Carriers and Non-carriers in the NAFLD+CHD Patients

Parameters Carriers (n = 94) Non-carriers (n = 60) Statistics P value
Male/Female 50/44 30/30 χ2 = 0.149 0.699
Age, y 63.34 ± 10.53 66.58 ± 10.92 t = −1.837 0.068
BMI, kg/m2 25.54 ± 3.24 25.35 ± 3.21 t = 0.344 0.731
ALT, U/L 23.72 (17.16, 37.60) 23.30 (14.58, 32.86) Z = − 1.106 0.269
AST, U/L 21.72 (17.37, 32.15) 20.12 (15.67, 32.54) Z = −0.728 0.467
GGT, U/L 32.39 (22.76, 44.39) 29.28 (19.67, 40.77) Z = −1.384 0.166
ALP, U/L 80.61 (65.89, 98.21) 76.27 (62.27, 89.86) Z = −0.947 0.344
TG, mmol/L 1.70 (1.31, 2.21) 1.40 (1.00, 2.09) Z = −1.932 0.053
TC, mmol/L 4.66 (3.73, 5.67) 4.54 (3.75, 5.34) Z = −0.943 0.346
HDL, mmol/L 1.04 (0.92, 1.17) 0.95 (0.82, 1.08) Z = −2.435 0.015
LDL, mmol/L 2.80 (2.08, 3.46) 2.88 (2.03, 3.33) Z = −0.369 0.712
TBIL, umol/L 13.30 (9.70, 17.07) 12.48 (9.42, 16.48) Z = −0.513 0.608
FPG, mmol/L 5.64 (4.65, 7.16) 5.79 (4.67, 6.87) Z = −0.371 0.711
HHS Vulnerability Disclosure